(Q27682427)

2

0 references

Masaaki Nakashima

3

0 references

Mayumi Imahashi

4

0 references

Yuriko Naganawa

5

0 references

Teppei Kurosawa

6

0 references

Yoshiyuki Yokomaku

7

0 references

Takashi Yamane

8

0 references

Nobuhisa Watanabe

9

0 references

Atsuo Suzuki

10

0 references

Wataru Sugiura

11

0 references

Yasumasa Iwatani

Nature Structural & Molecular Biology

12

0 references

publication date

October 2012

0 references

published in

0 references

volume

19

0 references

issue

10

0 references

page(s)

1005-10

0 references

cites work

HIV-1 Vif, APOBEC, and intrinsic immunity

1 reference

Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business

21 April 2017

1 reference

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

21 April 2017

1 reference

A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity

21 April 2017

1 reference

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

21 April 2017

1 reference

Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation

21 April 2017

1 reference

Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G

21 April 2017

1 reference

Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G

21 April 2017

1 reference

Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications

21 April 2017

1 reference

Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces

21 April 2017

1 reference

The APOBEC-2 crystal structure and functional implications for the deaminase AID

21 April 2017

1 reference

Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.

21 April 2017

1 reference

All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition

21 April 2017

1 reference

Features and development of Coot

21 April 2017

1 reference

Refinement of macromolecular structures by the maximum-likelihood method

21 April 2017

1 reference

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

21 April 2017

1 reference

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

21 April 2017

1 reference

MOLREP: an Automated Program for Molecular Replacement

21 April 2017

1 reference

Guidelines for naming nonprimate APOBEC3 genes and proteins

21 April 2017

1 reference

Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection

31 March 2020

1 reference

T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction

31 March 2020

1 reference

Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.

31 March 2020

1 reference

Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.

31 March 2020

1 reference

A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor

31 March 2020

1 reference

A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action

31 March 2020

1 reference

A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

31 March 2020

1 reference

A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif

31 March 2020

1 reference

Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex

31 March 2020

1 reference

APOBEC2 is a monomer in solution: implications for APOBEC3G models

31 March 2020

1 reference

HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain

31 March 2020

1 reference

Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

31 March 2020

1 reference

Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity

31 March 2020

1 reference

Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities

31 March 2020

1 reference

Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors

31 March 2020

1 reference

Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction

31 March 2020

1 reference

Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif

31 March 2020

1 reference

Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.

31 March 2020

1 reference

Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation

31 March 2020

1 reference

The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity

31 March 2020

1 reference

Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression

31 March 2020

1 reference

Processing of X-ray diffraction data collected in oscillation mode

31 March 2020

1 reference